publication venue for
- Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia. 73:e22084. 2019
- The comparative effects of environmental enrichment with exercise and serotonin transporter blockade on serotonergic neurons in the dorsal raphe nucleus. 66:465-470. 2012
- Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra. 65:1166-1172. 2011
- Curcumin prevents haloperidol‐induced development of abnormal oro‐facial movements: Possible implications of Bcl‐XL in its mechanism of action. 65:788-794. 2011
- MDMA-evoked changes in the binding of dopamine D2receptor ligands in striatum of rats with unilateral serotonin depletion. 64:70-82. 2010
- Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. 63:662-672. 2009
- Differential modulation of a 40 kDa catecholamine regulated protein in the core and shell subcompartments of the nucleus accumbens following chronic quinpirole and haloperidol administration in the rat. 61:835-842. 2007
- A PET study of effects of chronic 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) on serotonin markers in Göttingen minipig brain. 61:478-487. 2007
- Psychosis pathways converge via D2High dopamine receptors. 60:319-346. 2006
- Inhibition of [11C]mirtazapine binding by α2-adrenoceptor antagonists studied by positron emission tomography in living porcine brain. 59:463-471. 2006
- Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography. 59:418-426. 2006
- Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: Comparison with results in vivo. 59:211-219. 2006
- Interaction between LSD and dopamine D2/3 binding sites in pig brain. 56:198-204. 2005
- Electron spin resonance spectroscopy reveals alpha‐phenyl‐N‐tert‐butylnitrone spin‐traps free radicals in rat striatum and prevents haloperidol‐induced vacuous chewing movements in the rat model of human tardive dyskinesia. 54:156-163. 2004
- Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine. 52:153-162. 2004
- Asymmetric modulation of a catecholamine‐regulated protein in the rat brain, following quinpirole administration. 49:261-269. 2003
- Cocaine treatment increases expression of a 40 kDa catecholamine‐regulated protein in discrete brain regions. 47:33-44. 2003
- Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease: Correlation with muscarinic M1 receptor binding parameters. 47:58-65. 2003
- Unique changes in synaptic morphology following tetanization under pharmacological blockade. 47:77-86. 2003
- The cholinergic system modulates kindling and kindling‐induced mossy fiber sprouting. 44:132-138. 2002
- Sequential changes in the synaptic structural profile following long-term potentiation in the rat dentate gyrus: III. Long-term maintenance phase. 40:74-84. 2001
- Morphology of layer III pyramidal neurons is altered following induction of LTP in sensorimotor cortex of the freely moving rat. 37:16-22. 2000
- Sequential changes in the synaptic structural profile following long-term potentiation in the rat dentate gyrus. II. Induction / early maintenance phase. 36:286-296. 2000
- GABAergic modulation of neocortical long-term potentiation in the freely moving rat. 35:120-128. 2000
- Pharmacokinetics of radiotracers in human plasma during positron emission tomography. 34:124-134. 1999
- Sequential changes in the synaptic structural profile following long-term potentiation in the rat dentate gyrus: I. The intermediate maintenance phase. 31:97-107. 1999
- Role of glutamate receptor subtypes in the differential release of somatostatin, neuropeptide Y, and substance P in primary serum-free cultures of striatal neurons. 27:161-167. 1997
- Brain region-specific and time-dependent decreases of G?i2 in amygdala-kindled rats. 22:226-231. 1996
- Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes. 2:463-467. 1988